Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Gracell Biotechnologies Inc. GRCL

Full chart Compare
Set alert

Price alert · GRCL

All alert types
10.25 0.00 (+0.00%)

At closeFeb 21, 2024, 4:00 PM EST

10.17 Day range 10.28
1.40 52-week range 10.44

Analyst view

Consensus: hold

Hold
Price target (mean) 10.58 +3.2% upside
Target (low)
10.00
Target (mean)
10.58
Target (high)
11.50
Ratings (-1m) 9 5 buy · 4 hold · 0 sell
  • Strong buy2
  • Buy3
  • Hold4
  • Sell0
  • Strong sell0

Recommendation trend

  • 1 month ago 9
  • 2 months ago 9

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

GRCL analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.04-0.04 – -0.04-0.30+86.7%00.0%1
Next quarter-0.04-0.04 – -0.04-0.35+88.6%00.0%1
Current year-0.91-0.91 – -0.91-1.30+30.0%00.0%1
Next year-0.18-0.18 – -0.18-0.91+80.2%00.0%1

Upgrades and downgrades

The latest rating changes

GRCL analyst upgrades and downgrades
DateFirmActionFromTo
Oct 18, 2023StifelInitiated—Buy
Sep 4, 2023Cantor FitzgeraldReiteratedOverweightOverweight
Aug 29, 2023Cantor FitzgeraldReiteratedOverweightOverweight
Aug 28, 2023CitigroupMaintainedBuyBuy
Aug 13, 2023HC Wainwright & Co.MaintainedBuyBuy
Jun 12, 2023BTIGMaintainedBuyBuy
May 25, 2023HC Wainwright & Co.ReiteratedBuyBuy
Feb 15, 2023HC Wainwright & Co.Reiterated—Buy
Feb 5, 2023HC Wainwright & Co.Reiterated—Buy
Dec 7, 2022HC Wainwright & Co.Initiated—Buy
Sep 21, 2022CitigroupInitiated—Buy
May 31, 2022Cantor FitzgeraldInitiated—Overweight
Apr 3, 2022BTIGInitiated—Buy
Feb 2, 2021CitigroupInitiated—Buy
Feb 1, 2021Piper SandlerInitiated—Overweight
Feb 1, 2021Wells FargoInitiated—Overweight
Feb 1, 2021JefferiesInitiated—Buy